Atlas Trials

Evaluation of The Performance of Retinow AI Software

Clinical trial NCT06645964 · COMPLETED

Trial details

NCT number
NCT06645964
Sponsor
Retinow Health Technologies and R&D Industry Joint Stock Company
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetic RetinopathyGlaucomaMacular Degeneration
Start date
2023-06-01
Primary completion
2023-10-01
Enrollment
915

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.